HIV News and Research

RSS

UCLA study shows how cocaine makes immune cells susceptible to HIV

In many ways, the spread of HIV has been fueled by substance abuse. Shared needles and drug users' high-risk sexual behaviors are just some of the ways that narcotics such as cocaine have played a key role in the AIDS epidemic in much of the world.

3 Oct 2013

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

New York City's plan to solicit bids for health insurance for hundreds of thousands of workers has been put on hold. A Manhattan judge on Monday granted a preliminary injunction preventing the City from issuing the bids. A group of unions sued the city Aug. 10, shortly after Mayor Michael Bloomberg said the city was planning to seek bids within days. Bloomberg said the request for proposals will look to save up to $400 million a year (10/1)

2 Oct 2013

Mutant protein blocks HIV infection and transmission, scientists find

A mutant of an immune cell protein called ADAP (adhesion and degranulation-promoting adaptor protein) is able to block infection by HIV-1 (human immunodeficiency virus 1), new University of Cambridge research reveals. The researchers, who were funded by the Wellcome Trust, believe that their discovery will lead to new ways of combatting HIV.

2 Oct 2013

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

New data from Boehringer Ingelheim's hepatitis C virus clinical development program have been accepted for presentation at the 64th Annual Meeting of the American Association for the Study of Liver Diseases, also known as The Liver Meeting®, taking place November 1-5 in Washington, D.C.

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

First Edition: October 1, 2013

Today's headlines detail how the federal government has been shutdown as a result of the ongoing congressional battle over the health law. Still, even as House and Senate lawmakers were unable to overcome this issue to reach a deal to provide funding to continue government operations, Oct. 1 is still the official launch of the overhaul's online insurance marketplaces.

1 Oct 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

1 Oct 2013

ABAM Foundation receives $2M grant to establish Center for Physician Training in Addiction Medicine

The Conrad N. Hilton Foundation has awarded the American Board of Addiction Medicine (ABAM) Foundation a three-year, $2 million grant to establish The National Center for Physician Training in Addiction Medicine.

1 Oct 2013

Use of cocaine may increase one's vulnerability to HIV infection

Cocaine use may increase one's vulnerability to HIV infection, according to a new research report published in the Journal of Leukocyte Biology. In the report, scientists show that cocaine alters immune cells, called "quiescent CD4 T cells," to render them more susceptible to the virus, and at the same time, to allow for increased proliferation of the virus.

1 Oct 2013

Avahan AIDS initiative effective at controlling HIV infections in India

A programme funded by the Bill & Melinda Gates Foundation may have saved around 600,000 people in India from becoming infected with HIV over the course of a decade, according to a new report.

1 Oct 2013

Mylan Pharmaceuticals launches Voriconazole for Oral Suspension

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole for Oral Suspension, 40 mg/mL, which is the first generic version of Pfizer's VFEND for Oral Suspension.

30 Sep 2013

Patients treated by ID physicians less likely to die in hospital

In a first-of-its-kind study to evaluate the impact of a medical specialty on patient outcomes, researchers found that hospitalized patients with severe infections such as meningitis and Clostridium difficile are significantly less likely to die if they receive care from an infectious diseases specialist. The study, which analyzed nearly 130,000 Medicare patient cases, is now available online and will be published in the December 15 issue of Clinical Infectious Diseases.

30 Sep 2013

New intravaginal ring delivers drug effectively, guards against HIV for 1 month

It's often said that the HIV/AIDS epidemic has a woman's face. The proportion of women infected with HIV has been on the rise for a decade; in sub-Saharan Africa, women constitute 60 percent of people living with disease. While preventative drugs exist, they have often proven ineffective, especially in light of financial and cultural barriers in developing nations.

28 Sep 2013

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

...

27 Sep 2013

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

America's lockups are its new asylums. After scores of state mental institutions were closed beginning in the 1970s, few alternatives materialized. … The country's three biggest jail systems -- Cook County, in Illinois; Los Angeles County; and New York City -- are on the front lines. With more than 11,000 prisoners under treatment on any given day, they represent by far the largest mental-health treatment facilities in the country. By comparison, the three largest state-run mental hospitals have a combined 4,000 beds.

27 Sep 2013

NIH program provides $22M for low- and middle-income countries to combat HIV/AIDS epidemic

A new NIH program supporting HIV-related research training will provide $22 million over five years for activities in 15 low- and middle-income countries. The Fogarty International Center's HIV Research Training Program is issuing 22 awards, which are intended to strengthen the ability of the grantee institutions to combat the HIV/AIDS epidemic, while building expertise in a particular scientific or critical research infrastructure area.

27 Sep 2013

'Jekyll-and-Hyde' protein could be potent target for developing new cancer drugs

The mood changes of a 'Jekyll-and-Hyde' protein, which sometimes boosts tumour cell growth and at other times suppresses it, have been explained in a new study led by Oxford University researchers.

27 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Janssen R&D Ireland announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis against HIV infection.

25 Sep 2013

Viewpoints: GOP's 'charge into the fixed bayonets;' Republican health plan is superior to Obama's; Congressional hypocrisy on its health policy

So House Republicans have passed and sent to the Senate a budget that includes no funding for the Affordable Care Act, setting up a political showdown that could result in a government shutdown. We wish the GOP luck, since we support the policy if not the strategy. But however this charge into the fixed bayonets turns out, we hope the folks who planned it will take responsibility for what happens now (9/23).

25 Sep 2013

HIV News and Research

UCLA study shows how cocaine makes immune cells susceptible to HIV

State highlights: NYC's plan to get bids for worker coverage meets roadblock; Iowa waits for Medicaid expansion waiver, readies enrollment

Mutant protein blocks HIV infection and transmission, scientists find

Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

First Edition: October 1, 2013

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

ABAM Foundation receives $2M grant to establish Center for Physician Training in Addiction Medicine

Use of cocaine may increase one's vulnerability to HIV infection

Avahan AIDS initiative effective at controlling HIV infections in India

Mylan Pharmaceuticals launches Voriconazole for Oral Suspension

Patients treated by ID physicians less likely to die in hospital

New intravaginal ring delivers drug effectively, guards against HIV for 1 month

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

NIH program provides $22M for low- and middle-income countries to combat HIV/AIDS epidemic

'Jekyll-and-Hyde' protein could be potent target for developing new cancer drugs

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Janssen signs license agreement with PATH for early development HIV-1 medicine rilpivirine

Viewpoints: GOP's 'charge into the fixed bayonets;' Republican health plan is superior to Obama's; Congressional hypocrisy on its health policy

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News